Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors, World Journal of Gastrointestinal Oncology, vol.2, issue.11, pp.407-416, 2010. ,
DOI : 10.4251/wjgo.v2.i11.407
Clinical and Pathologic Features of Proximal Biliary Strictures Masquerading as Hilar Cholangiocarcinoma, Journal of the American College of Surgeons, vol.201, issue.6, pp.862-869 ,
DOI : 10.1016/j.jamcollsurg.2005.07.011
Cholangiocarcinoma, The Lancet, vol.366, issue.9493, pp.1303-1314, 2005. ,
DOI : 10.1016/S0140-6736(05)67530-7
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis., Gut, vol.38, issue.4, pp.610-615, 1996. ,
DOI : 10.1136/gut.38.4.610
Cholangiocarcinoma, The Lancet, vol.383, issue.9935, pp.2168-2179, 2014. ,
DOI : 10.1016/S0140-6736(13)61903-0
Review article: the modern diagnosis and therapy of cholangiocarcinoma, Alimentary Pharmacology and Therapeutics, vol.7, issue.6 ,
DOI : 10.1097/00000658-200008000-00003
A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease, Clinical Radiology, vol.54, issue.8, pp.513-520, 1999. ,
DOI : 10.1016/S0009-9260(99)90848-6
Biliary Dilatation: Differentiation of Benign from Malignant Causes???Value of Adding Conventional MR Imaging to MR Cholangiopancreatography, Radiology, vol.214, issue.1, pp.173-181, 2000. ,
DOI : 10.1148/radiology.214.1.r00ja35173
Endoscopic Cannulation of the Ampulla of Vater, Annals of Surgery, vol.167, issue.5, pp.752-756, 1968. ,
DOI : 10.1097/00000658-196805000-00013
Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts, Scand J Gastroenterol, vol.10, pp.829-831, 1975. ,
Risk factors for complications after performance of ERCP Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years, Gastrointest Endosc Gastrointest Endosc, vol.5670, pp.652-65680, 2002. ,
Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and metaanalysis Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature, Gastrointest Endosc J Surg Res, vol.79184, issue.16, pp.783-789304, 2013. ,
Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis, Gastrointestinal Endoscopy, vol.81, issue.1, pp.168-176, 2015. ,
DOI : 10.1016/j.gie.2014.09.017
Int??r??t de l???association cytologie de la bile et brossage de la voie biliaire principale : ??tude comparative chez 115 patients, Annales de Pathologie, vol.26, issue.5, pp.361-367, 2006. ,
DOI : 10.1016/S0242-6498(06)70741-6
Intraductal aspiration: a promising new tissue-sampling technique for the diagnosis of suspected malignant biliary strictures, Gastrointestinal Endoscopy, vol.75, issue.4, pp.798-804, 2012. ,
DOI : 10.1016/j.gie.2011.12.005
Complications of diagnostic and therapeutic ERCP: a prospective multicenter study, The American Journal of Gastroenterology, vol.209, issue.2, pp.417-423, 2001. ,
DOI : 10.1016/S0140-6736(89)90602-8
Identification of cholangiocarcinoma by using the Spyglass Spyscope system for peroral cholangioscopy and biopsy collection Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience, Clin Gastroenterol Hepatol Gastrointest Endosc, vol.1074, pp.466-471961, 2011. ,
Sensitivity of alternative testing for pancreaticobiliary cancer: a 10-y review of the literature, Journal of Surgical Research, vol.190, issue.2, pp.535-547, 2014. ,
DOI : 10.1016/j.jss.2014.04.014
Cholangiocarcinoma, The Lancet, vol.366, issue.9493, pp.1303-1314, 2005. ,
DOI : 10.1016/S0140-6736(05)67530-7
Burden of digestive diseases in the United States Part III ,
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors, World Journal of Gastrointestinal Oncology, vol.2, issue.11, pp.407-416, 2010. ,
DOI : 10.4251/wjgo.v2.i11.407
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000454
Cholangiocarcinoma, The Lancet, vol.383, issue.9935, pp.2168-2179, 2014. ,
DOI : 10.1016/S0140-6736(13)61903-0
Review article: the modern diagnosis and therapy of cholangiocarcinoma, Alimentary Pharmacology and Therapeutics, vol.7, issue.6, pp.1287-1296, 2006. ,
DOI : 10.1097/00000658-200008000-00003
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept, World Journal of Hepatology, vol.2, issue.12, pp.419-427, 2010. ,
DOI : 10.4254/wjh.v2.i12.419
Clinical diagnosis and staging of cholangiocarcinoma, Nature Reviews Gastroenterology & Hepatology, vol.31, issue.9, pp.512-522, 2011. ,
DOI : 10.1038/nrgastro.2011.131
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma, Gastroenterology, vol.145, issue.6, pp.1215-1229, 2013. ,
DOI : 10.1053/j.gastro.2013.10.013
Pathology and Genetics of Tumours of the Digestive System 13. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma, International Agency for Research on Cancer (IARC) Oncogene, vol.25, pp.3818-3822, 2000. ,
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity, World Journal of Gastrointestinal Oncology, vol.4, issue.5, pp.94-102, 2012. ,
DOI : 10.4251/wjgo.v4.i5.94
mTOR signaling in growth control and disease Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends, Cell J Hepatol, vol.14960, issue.20, pp.274-293855, 2012. ,
Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression, Cancer Research, vol.66, issue.21 ,
DOI : 10.1158/0008-5472.CAN-06-2130
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors, Gastroenterology, vol.142, pp.1021-1031, 2012. ,
Role of Transforming Growth Factor ? in Human Disease, New England Journal of Medicine, vol.342, pp.1350-1358, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-00562819
Genetic profiling of intrahepatic cholangiocarcinoma, Current Opinion in Gastroenterology, vol.28, issue.3 ,
DOI : 10.1097/MOG.0b013e3283523c7e
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis, J Hepatol, vol.58, pp.1188-1193, 2013. ,
Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination, HPB, vol.13, issue.5, pp.356-360, 2011. ,
DOI : 10.1111/j.1477-2574.2011.00298.x
Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts, Scand J Gastroenterol, vol.10, pp.829-831, 1975. ,
Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature, Gastrointest Endosc J Surg Res, vol.79184, issue.32, pp.783-789304, 2013. ,
Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis, Gastrointestinal Endoscopy, vol.81, issue.1, pp.168-176, 2015. ,
DOI : 10.1016/j.gie.2014.09.017
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment, J Clin Oncol, vol.29, pp.3140-3145, 2011. ,
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers e83; quiz e14. 37. Kuhlmann JB, Blum HE. Locoregional therapy for cholangiocarcinoma, Gastroenterology Curr Opin Gastroenterol, vol.14329, pp.88-98324, 2012. ,
Radiofrequency Ablation for the Treatment of Primary Intrahepatic Cholangiocarcinoma, American Journal of Roentgenology, vol.196, issue.2, pp.205-209, 2011. ,
DOI : 10.2214/AJR.10.4937
Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome, Clinical Imaging, vol.38, issue.4, pp.490-494, 2014. ,
DOI : 10.1016/j.clinimag.2014.01.013
Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma, Clin Radiol, vol.66, pp.322-328, 2011. ,
Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study, World Journal of Surgery, vol.362, issue.9, pp.2083-2091, 2011. ,
DOI : 10.1007/s00268-011-1171-y
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma, Radiation Oncology, vol.7, issue.1, p.67, 2012. ,
DOI : 10.1007/s11894-008-0022-y
Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma, Radiation Oncology Journal, vol.32, issue.3 ,
DOI : 10.3857/roj.2014.32.3.163
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma ,
Essai de phase II multicentrique randomisé comparant une radiochimiothérapie (RTCT) à une chimiothérapie seule (CT) associant la gemcitabine et l'oxaliplatine dans les cancers des voies biliaires localement avancés non résécables (FFCD9902) ,
! ! 81! 48 ,
Treatment of unresectable cholangiocarcinoma using yttrium-90 ,
Intraarterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis ,
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis, Journal of Clinical Oncology, vol.30, issue.16, pp.1934-1940, 2012. ,
DOI : 10.1200/JCO.2011.40.5381
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer, New England Journal of Medicine, vol.362, pp.1273-1281, 2010. ,
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study, Ann Oncol, vol.15, pp.1339-1343, 2004. ,
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study, The Lancet Oncology, vol.13, issue.2, pp.181-188, 2012. ,
DOI : 10.1016/S1470-2045(11)70301-1
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial, The Lancet Oncology, vol.15, issue.8, pp.819-828, 2014. ,
DOI : 10.1016/S1470-2045(14)70212-8
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials, Br J Cancer, vol.96, pp.896-902, 2007. ,
EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis, Gastrointestinal Endoscopy, vol.75, issue.2, pp.319-331, 2012. ,
DOI : 10.1016/j.gie.2011.08.049
Endobiliary brush biopsy ,
Risk factors for complications after performance of ERCP Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years, Gastrointest Endosc Gastrointest Endosc, vol.5670, pp.652-65680, 2002. ,
Complications of ERCP, Gastrointest Endosc, vol.75, pp.467-473, 2012. ,
Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review, Gastrointest Endosc, 2015. ,
Sensitivity of alternative testing for pancreaticobiliary cancer: a 10-y review of the literature, J Surg Res, vol.190, pp.535-547, 2014. ,
ancer) and S100A4???protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies, Diagnostic Cytopathology, vol.32, issue.8, pp.561-567, 2008. ,
DOI : 10.1002/dc.20836